A detailed history of State Street Corp transactions in Alector, Inc. stock. As of the latest transaction made, State Street Corp holds 2,789,877 shares of ALEC stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,789,877
Previous 3,915,169 28.74%
Holding current value
$14.2 Million
Previous $23.6 Million 46.26%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.19 - $6.23 $4.71 Million - $7.01 Million
-1,125,292 Reduced 28.74%
2,789,877 $12.7 Million
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $4.54 Million - $6.44 Million
797,640 Added 25.59%
3,915,169 $23.6 Million
Q4 2023

Feb 14, 2024

BUY
$3.77 - $8.39 $1.06 Million - $2.36 Million
280,822 Added 9.9%
3,117,529 $24.9 Million
Q3 2023

Nov 14, 2023

BUY
$5.2 - $8.77 $611,312 - $1.03 Million
117,560 Added 4.32%
2,836,707 $18.4 Million
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $4.96 Million - $6.71 Million
-846,184 Reduced 23.73%
2,719,147 $16.3 Million
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $1.96 Million - $3.3 Million
335,814 Added 10.4%
3,565,331 $22.1 Million
Q4 2022

Feb 14, 2023

SELL
$6.88 - $9.55 $440,870 - $611,964
-64,080 Reduced 1.95%
3,229,517 $29.8 Million
Q3 2022

Nov 15, 2022

SELL
$8.19 - $13.2 $5.08 Million - $8.19 Million
-620,739 Reduced 15.86%
3,293,597 $31.2 Million
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $598,558 - $1.11 Million
78,243 Added 2.04%
3,914,336 $39.8 Million
Q1 2022

May 16, 2022

BUY
$13.02 - $20.78 $10.1 Million - $16.1 Million
772,398 Added 25.21%
3,836,093 $54.7 Million
Q4 2021

Feb 14, 2022

SELL
$19.35 - $25.54 $10.1 Million - $13.3 Million
-520,824 Reduced 14.53%
3,063,695 $63.3 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $18.3 Million - $33.3 Million
843,189 Added 30.76%
3,584,519 $81.8 Million
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $437,627 - $634,700
28,234 Added 1.04%
2,741,330 $57.1 Million
Q1 2021

May 17, 2021

SELL
$14.84 - $22.23 $5.02 Million - $7.52 Million
-338,435 Reduced 11.09%
2,713,096 $54.6 Million
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $5.03 Million - $8.93 Million
-534,865 Reduced 14.91%
3,051,531 $46.2 Million
Q3 2020

Nov 10, 2020

BUY
$10.54 - $24.96 $18.7 Million - $44.3 Million
1,776,001 Added 98.1%
3,586,396 $37.8 Million
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $14.8 Million - $22.4 Million
676,606 Added 59.68%
1,810,395 $44.2 Million
Q1 2020

May 11, 2020

BUY
$16.25 - $35.28 $18.4 Million - $40 Million
1,133,789 New
1,133,789 $27.4 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $421M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.